IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity

Area of Science:

• Immunology
• Oncology
• Proteomics

Background:

• Sentinel nodes (SNs) are crucial for anti-tumor T cell responses.
• Tumor immune escape, driven by regulatory T cells (Tregs), hinders immunotherapy.
• Understanding Treg function in SNs is vital for developing new cancer treatments.

Purpose of the Study:

• To investigate proteomic alterations in SN-resident T cells due to tumors.
• To identify key proteins in SN T cell signaling, particularly in Tregs.
• To elucidate the role of Tregs and IL-16 in tumor immune escape within SNs.

Main Methods:

• Proteomic analysis using mass spectrometry on T cell subsets from bladder cancer patients and healthy donors.
• Flow cytometry for T cell isolation.
• Validation and functional studies to assess Treg signaling and IL-16 processing.

Main Results:

• Proteomic analysis revealed upregulated growth and immune signaling pathways in SN-resident Tregs.
• Centrality analysis identified Interleukin-16 (IL-16) as a key cytokine in the SN-Treg signaling network.
• Tumor-secreted factors activate caspase-3, increasing bioactive IL-16 processing and Treg suppressive function.

Conclusions:

• Tregs in SNs exposed to bladder tumor factors exhibit enhanced immune and growth signaling.
• Altered IL-16 processing in Tregs represents a novel mechanism of tumor immune escape.
• Targeting IL-16 signaling in Tregs could offer new immunotherapy strategies.